M+QuickMedCalc
Educational reference only. Not a diagnostic tool. See full disclaimer.
HepaticAPRI

AST-to-Platelet Ratio Index Calculator

Calculate APRI from AST, laboratory AST ULN, and platelet count.

Content updated: View sources

U/L
U/L

AST-to-Platelet Ratio Index

Noninvasive laboratory index; no fibrosis category is assigned

AST/ULN: · platelets: ×10⁹/L

About

The AST-to-Platelet Ratio Index (APRI) is a noninvasive index originally developed in treatment-naive adults with chronic hepatitis C. This page reports the arithmetic without assigning a fibrosis stage.

Formula

APRI = [(AST ÷ laboratory AST ULN) × 100] ÷ platelet count (×10⁹/L)

Interpretation

What the result represents: AST relative to the reporting laboratory upper limit, scaled by platelet count.

Input units: AST and its laboratory ULN use U/L. Platelets may use ×10³/µL, ×10⁹/L, or cells/µL and are normalized to ×10⁹/L.

Worked example: AST 80 U/L, AST ULN 40 U/L, and platelets 200 ×10⁹/L gives APRI 1.00.

Applicable population: Originally derived for chronic hepatitis C; performance and cutoffs differ by liver disease, population, and clinical purpose.

Interpretation limitations: APRI does not by itself diagnose or exclude fibrosis or cirrhosis. AST from nonhepatic causes and platelet changes from other conditions affect the index. Interpret with clinical context, other noninvasive assessment, imaging, and specialist evaluation where appropriate.

References

  1. Wai CT, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in chronic hepatitis C. Hepatology. 2003;38:518-526.
  2. WHO. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. 2018.

FAQ

Related Calculators

Disclaimer

Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.